For example, unrestricted ketogenic diets have been shown to increase mortality in mice, and supplementing the OHB precursor 1,3-butanediol has been shown to increase middle-aged mortality in normal mice but extend lifespan in aged mice (Tomita et al
Following chemotherapy, macrophages secrete interleukin-18 (IL-18), which in turn upregulates L-amino acid transporter protein 2 (LAT2) expression in tumour cells
48%, p = 0.02) than the placebo group
We followed the BCS approach as it provides a surrogate for in vivo bioequivalence studies
Heres how to make the most of it: Take advantage of the availability
The therapeutic potential of ferroptosis inhibition in MASLD merits further research, bearing in mind the potential need of patient stratification